Reconstructive surgical therapy of peri-implantitis-related bone defects: Application of a bovine-derived bone xenograft with or without a resorbable collagen membrane. Multicenter controlled randomized clinical trial

Periocentrum Bilbao0 个研究点目标入组 43 人开始时间: 2019年6月3日最近更新: 2023年3月27日

适应症

试验速览

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36802084/ (added 17/03/2023)

•1. Show radiographically peri-implant intraosseous defects of at least 3mm depth.
•2. Depth of clinical probing = 5mm with bleeding and/or suppuration.
•3. Intra-surgically, the infra-osseous defect must have at least one intraosseous component of 3mm and a width of no more than 4mm.
•4. The implant to be treated must have been in function for at least 12 months.

•1. Has diabetes mellitus, hyperparathyroidism and/or osteomalacia.
•2. Treated with corticosteroids.
•3. Medicated with drugs that induce gingival hyperplasia.
•4. Allergic to penicillin or who have taken antibiotics in the last 6 months.
•5. Pregnant or breast-feeding patients.
•6. Patients with osteoporosis.
•7. Impossibility of stabilizing bovine bone with collagen or primary closure of soft tissue.
•8. Patients with collagen allergy.
•9. Patients treated with radiotherapy.

发起方

Periocentrum Bilbao